Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mFOLFOX6 + Bevacizumab + Sintilimab in Local Advanced MSS Colorectal Cancer
NCT04895137Phase 2Completed
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- May 2021
- Primary completion
- Sep 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in colorectal cancer (CRC), sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Started May 2021; status: completed.
02
Drugs
sintilimab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04895137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04895137.